Skip to content

Traditional Chinese medicine (TCM) collaborative care for patients with Poststroke depression: a randomized controlled trial

Traditional Chinese medicine (TCM) collaborative care for patients with Poststroke depression: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029554
Enrollment
Unknown
Registered
2020-02-04
Start date
2020-02-15
Completion date
Unknown
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poststroke depression

Interventions

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Improve related medical examinations. The test results are in line with the diagnostic criteria for depression in the American Mental Disorder Classification and Diagnostic Standards; 2. The duration of cognitive impairment exceeds 3 months; 3. The vital signs are stable and the stroke recovery period; 4. the first new onset stroke; 5. Patients with mild or moderate depression; 6. HAMD score before treatment was more than 20 points.

Exclusion criteria

Exclusion criteria: 1. Have a history of depression; 2. Have the dysfunction in important organs such as heart, liver, spleen, lung, and kidney; 3. Serious suicidal tendency; 4. Patients with primary psychosis; 5. Patients with deafness, malignant tumors, and Reject acupuncture.

Design outcomes

Primary

MeasureTime frame
The Hamilton Depression Scale (HAMD);

Countries

China

Contacts

Public ContactZhu Linqun

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing China

2080146184@qq.com+86 19801206964

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026